StockData
Xtant Medical Holdings, Inc. logo

Xtant Medical Holdings, Inc. (XTNT) stock

XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/3074% below fair value
$0.27−0.00 (-1.31%)

Close on Nov 13, 2026Market cap $38.12MP/E –Yield –

Xtant Medical price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Xtant Medical's price to sales ratio was 0.3× on Nov 10, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.3× to 2.1×, with a median of 0.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20260.3×−0.5
2025Dec 31, 20250.8×+0.3
2024Dec 31, 20240.5×−1.3
2023Dec 29, 20231.9×+0.7
2022Dec 30, 20221.2×+0.3
2021Dec 31, 20210.9×+0.6
2020Dec 31, 20200.3×−0.0
2019Dec 31, 20190.3×+0.0
2018Dec 31, 20180.3×−1.1
2017Dec 29, 20171.4×+0.5
2016Dec 30, 20160.9×−7.7
2015Dec 31, 20158.7×+1.6
2014Dec 31, 20147.0×−2.4
2013Dec 31, 20139.4×−9.5
2012Dec 31, 201218.9×−33.4
2011Dec 30, 201152.3×–

More Xtant Medical figures

See a number that looks wrong?